Bladder Cancer Diagnostics Market Research 2024: Forecasts to 2034 by Test Type, Stage, Cancer Type, and End-User
The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been ...
When ‘Cancer’ Gets in the Way of Treatment
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.
Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
The Program Committee of the AUA has accepted the Theralase®'s abstract titled: ' Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive ...
TipRanks on MSN3d
Theralase’s Innovative Bladder Cancer Treatment to be Highlighted at AUA Annual Meeting
Theralase Technologies ( ($TSE:TLT) ) has shared an update. Theralase Technologies announced that its interim clinical data on the light-activated ...
Theralase Technologies, Inc.: Theralase Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the resear ...
ImmunityBio announces Anktiva MAA accepted for review by EMA
ImmunityBio (IBRX) announced the European Medicines Agency has accepted for review and begun assessing the marketing authorization application ...